| Website | igea.it/index.php |
| Category | BioTech |
| Employees | |
| Founded | 1980 |
| Description | Clinical biophysics |
| VENTURE FUNDING | |
| Series A, 9/08 Innogest Atlante Ventures |
Founded in 1980 as a spin-off of the University of Modena, Igea focuses its activity on biomedical product development, in particular on the employment of non-ionizing physical energy in the medical field. The current spotlight of Igea is the oncology sector, which is expected to be the most important driver to accelerate the growth of the company: thanks to its proprietary technologies and strong know-how, Igea has developed and produced an innovative electronic systems for the treatment of surface cancer. The technologies on which the system is based are aimed to increase the anti-tumoral effectiveness of low permeant drugs possessing a high intrinsic cyto-toxicity or to destroy the tumor cells. Thanks to future developments in research and test activities Igea solutions are positioned to become useful in a wider range of pathologies and in particular in deep cancers.
